Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Over 90% of patients with type 2 diabetes have high chances of heart disease. This is because high blood sugar due to ...

Objective: This study assesses the effects of insulin pump therapy on diabetes control and family life in children 1 6 years old with type 1 diabetes. Research Design and Methods: Twenty-six ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.

PharmaSens, a developer of insulin patch pumps for people with diabetes, has appointed Robert A. Gabbay, MD, PhD, FACP and James L. Peterson to its board of directors.

For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because ... unexpectedly stop therapy. Medtronic, which has ...

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

"Pumps that have been dropped ... All users should also carry back-up insulin therapy at all times in case of an emergency. This recall does not involve removing all products.

1 mylife Loop consists of the mylife YpsoPump, a lightweight intuitive insulin pump, integrated with the CamAPS FX hybrid ...

Over 90% of patients with type 2 diabetes have high chances of heart disease. This is because high blood sugar due to ...